Browsing by Author Francis, P A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2017Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFTCoates, Alan; Abdi, Ehtesham; Colleoni, Marco; Fleming, G. F.; Francis, P A; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Parmar, Vani; Pinotti, Graziella; Regan, Meredith M.; Ruhstaller, Thomas; Salim, Muhammad; Spazzapan, Simon; Tondini, Carlo; Walley, B. A.; NH&MRC Clinical Trials CentreConcurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT, Annals of Oncology, vol.28, 9, 2017,pp 2225-2232
2012Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C(14)-erythromycin breath test and the antipyrine clearance testClarke, Stephen; Booth, R; Cullinane, Carleen; Francis, P A; Hatzimihalis, A; Michael, Michael; Milner, Alvin D.; O'Kane, C; Schlicht, S; Northern Clinical School: Kolling InstituteDocetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C(14)-erythromycin breath test and the antipyrine clearance test, Cancer Chemotherapy and Pharmacology, vol.69, 1, 2012,pp 125-135
2014Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)Boyle, Frances; Gebski, Val; Wilcken, Nicholas; Abdi, E; Bull, J; Chirgwin, Jacquie H; et al, Various; Francis, P A; Kannourakis, G; Leong, E; McCarthy, Nicole; Simpson, A; Veillard, Anne-Sophie; Zannino, D; Zdenkowski, Nicholas; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem), The Breast, vol.23, 2, 2014,pp 142-151
2015Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trialsCoates, Alan; Dell’Orto, Patrizia; Doimi, Franco; et al, Various; Fleming, G. F.; Francis, P A; Kammler, Roswitha; Pagani, Olivia; Regan, Meredith; Russo, Leila; Szoke, Janos; Walley, B; School of Public Health: Public HealthPredictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials, Breast Cancer Research and Treatment, vol.154, 2, 2015,pp 275-286
2008Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?Coates, Alan; et al, Various; Fleming, G. F.; Francis, P A; Pagani, Olivia; Perez, E. A.; Price, K N; Regan, Meredith M.; Thurlimann, Beat; Torrisi, R; Walley, B; School of Public Health: Public HealthPremenopausal endocrine-responsive early breast cancer: who receives chemotherapy?, Annals of Oncology, vol.19, 7, 2008,pp 1231-1241